Chevallard Daniel R. (CIK 0001706176)

Latest company ownership

Shares held
200,000
Last filed at
Mar 13, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
5,386
Last filed at
Nov 7, 2025
Confidence Score
83.8
2025Q4
Confidence Score History
2024Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 7, 2025 Nov 7, 2025 LENZ Therapeutics, Inc. CFO Buy 95.0 +2,198 68.95% ✗ $50K
May 14, 2024 May 15, 2024 LENZ Therapeutics, Inc. CFO Buy 91.3 +3,188 100.00% ✗ $50K
Feb 25, 2024 Feb 27, 2024 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,405 -3.22% ✗ $2.5K
Nov 25, 2023 Nov 28, 2023 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,720 -3.63% ✗ $1.9K
Aug 25, 2023 Aug 29, 2023 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,512 -3.54% ✗ $5.1K
May 25, 2023 May 26, 2023 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,635 -3.79% ✗ $5.2K
Feb 25, 2023 Feb 28, 2023 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,599 -3.89% ✗ $6.1K
Nov 25, 2022 Nov 29, 2022 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,532 -3.96% ✗ $9.6K
Aug 25, 2022 Aug 29, 2022 Viracta Therapeutics, Inc. CFO Sell 46.3 -3,655 -4.25% ✗ $14.7K
May 25, 2022 May 27, 2022 Viracta Therapeutics, Inc. CFO Sell 47.5 -3,596 -4.35% ✗ $6.8K
Feb 25, 2022 Mar 1, 2022 Viracta Therapeutics, Inc. CFO Sell 46.3 -3,998 -5.01% ✗ $11.1K
Nov 25, 2021 Nov 29, 2021 Viracta Therapeutics, Inc. CFO Sell 46.3 -7,579 -9.41% ✗ $36.5K